REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic Inc <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0409UBlackRock Group10 October 2014Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
BlackRock, Inc.
Companydealtin
Medtronic, Inc.
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 common shares
Dateofdealing
09 October 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
61,181,997 (6.24%)
44,054 (0.00%)
(2)Derivatives(otherthanoptions)
973 (0.00%)
4,724 (0.00%)
(3)Optionsandagreementstopurchase/sell
0 (0.00%)
65,200 (0.00%)
Total
61,182,970 (6.24%)
113,978 (0.01%)
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
903
USD 63.6500
Purchase
502
USD 63.9588
Purchase
145
USD 64.5431
Purchase
9,678
USD 65.4400
Purchase
42,987
USD 65.7300
Sale
2,436
USD 63.6500
Sale
2,490
USD 64.3783
Please note: there was also a Transfer In of 16,659 Shares
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)
CFD
Increasing Short
72
USD 64.0000
CFD
Increasing Short
647
USD 64.4219
CFD
Increasing Short
393
USD 65.2500
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)
(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)
(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)
Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevant
securitiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.
N/A
IsaSupplementalForm8attached?(Note9) YES
Dateofdisclosure
10 October 2014
Contactname
Tim Dudley
Telephonenumber
+44 20 7743 1540
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected
IfaconnectedEFM,statenatureofconnection(Note10)
Ap23
SUPPLEMENTALFORM8
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DETAILSOFOPENPOSITIONS
(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)
OPENPOSITIONS(Note1)
Productname,
e.g.calloption
Written,orpurchased
Numberofrelevant securitiestowhichtheoptionorderivativerelates
Exercise price(Note2)
Type,e.g.American,Europeanetc.
Expiry date
Call Option
Written
32,600
USD 64.50
American
03/10/2014
Call Option
Written
32,600
USD 65.00
American
18/10/2014
Notes
1. Wherethereareopenoptionpositionsoropenderivative positions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.
2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.
Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEEALEEFAFLFFF
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement